Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 17, 2023

BUY
$2.05 - $2.87 $82,000 - $114,800
40,000 Added 48.19%
123,000 $280,000
Q3 2022

Nov 02, 2022

BUY
$2.6 - $5.12 $13,000 - $25,600
5,000 Added 6.41%
83,000 $237,000
Q2 2022

Aug 12, 2022

SELL
$2.19 - $3.98 $1,752 - $3,184
-800 Reduced 1.02%
78,000 $193,000
Q1 2022

May 13, 2022

BUY
$3.28 - $7.12 $223,040 - $484,160
68,000 Added 629.63%
78,800 $301,000
Q4 2021

Feb 14, 2022

BUY
$6.55 - $13.25 $63,207 - $127,862
9,650 Added 839.13%
10,800 $71,000
Q3 2021

Nov 12, 2021

SELL
$7.29 - $11.0 $3,411 - $5,148
-468 Reduced 28.92%
1,150 $10,000
Q2 2021

Aug 10, 2021

BUY
$9.87 - $13.32 $15,969 - $21,551
1,618 New
1,618 $18,000

Others Institutions Holding ME

About 23andMe Holding Co.


  • Ticker ME
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 259,768,000
  • Market Cap $992M
  • Description
  • 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...
More about ME
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.